Caricamento...
COVID-19 vaccine development: Time to consider SARS-CoV-2 challenge studies?
While a human challenge study holds the prospect of accelerating the development of a vaccine for the coronavirus SARS-CoV-2, it may be opposed due to risks of harm to participants and researchers. Given the increasing number of human deaths and severe disruption to lives worldwide, we argue that a...
Salvato in:
| Pubblicato in: | Vaccine |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier Ltd.
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7269942/ https://ncbi.nlm.nih.gov/pubmed/32540271 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2020.06.007 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|